Tag: Deviation

Understanding the Risks of QA Oversight Failures in Data Integrity During Review Processes In the fast-paced world of pharmaceutical manufacturing, maintaining data integrity (DI) is paramount. A recent case highlighted…

“`html Investigating Uncontrolled Spreadsheet Calculations During System Validation In pharmaceutical manufacturing, maintaining the integrity and reliability of data is paramount. A recent case highlighted a significant failure mode involving uncontrolled…

Case Study: Understanding and Addressing Audit Trail Deletion During Data Review In a recent audit of a pharmaceutical manufacturing facility, inspectors identified a concerning issue: the deletion of critical audit…

Breakdown of 483 Observations Due to Tolerated Data Integrity Lapses During System Validation The pharmaceutical industry is often faced with the daunting task of maintaining strict data integrity (DI) throughout…

Analyzing a QA Oversight Failure in Data Integrity During FDA Inspections Pharmaceutical manufacturing is an industry where quality assurance (QA) is paramount. A recent case study highlights a significant oversight…

Analyzing a QA Oversight Failure in Data Integrity During Review Processes In the highly regulated pharmaceutical industry, ensuring data integrity (DI) is paramount. A recent case study revealed a QA…

Analysis of Recurring Data Integrity Breaches During Data Review Processes In the complex landscape of pharmaceutical manufacturing, maintaining data integrity throughout all processes is crucial for compliance and product quality.…

Case Study: Addressing Shared Analyst Passwords and Ensuring Compliance in System Validation In a recent FDA inspection, a pharmaceutical manufacturing facility received a 483 observation citing the issue of shared…

Analysis of Backdated Laboratory Records During Internal Audit: Observations and Solutions In the world of pharmaceutical quality management, the integrity of data is paramount. This case study examines a realistic…

Remediation Failure Analysis of Uncontrolled Spreadsheet Calculations During FDA Inspection The scenario of uncontrolled spreadsheet calculations can emerge in any pharmaceutical manufacturing environment, leading to significant compliance risks. This article…

Risk of Warning Letters from Shared Analyst Passwords Found in Internal Audit In a recent internal audit at a pharmaceutical manufacturing facility, multiple instances of shared passwords among analysts were…

Risks of Backdated Laboratory Records During FDA Inspections: A Comprehensive Case Study In the pharmaceutical manufacturing environment, data integrity is crucial to establishing compliance with Good Manufacturing Practices (GMP). A…